This HTML5 document contains 133 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
n12http://dx.doi.org/10.1001/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34655367
rdf:type
wikibase:Item
schema:description
мақолаи илмӣ artigo científico 2007年論文 artikull shkencor article scientific 2007年论文 artículo científico publicado en 2007 mokslinis straipsnis artículu científicu espublizáu en 2007 מאמר מדעי научна статия videnskabelig artikel (udgivet 2007) ২০০৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ мақолаи илмӣ artykuł naukowy 2007年论文 επιστημονικό άρθρο наукова стаття, опублікована в листопаді 2007 scienca artikolo 2007年论文 บทความทางวิทยาศาสตร์ научни чланак 2007年論文 articolo scientifico 2007年論文 tieteellinen artikkeli vedecký článok wissenschaftlicher Artikel scientific article artikulong pang-agham article scientifique (publié 2007) 2007年论文 bài báo khoa học naučni članak 2007 թվականի նոյեմբերին հրատարակված գիտական հոդված سائنسی مضمون научная статья tudományos cikk 2007년 논문 2007年论文 vitenskapelig artikkel مقالة علمية 2007年論文 bilimsel makale 2007年論文 articol științific vetenskaplig artikel научни чланак 2007 nî lūn-bûn مقالهٔ علمی artigo científico (publicado na 2007) wetenschappelijk artikel 2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած article científic teaduslik artikkel artigo científico (publicado na 2007) vitskapeleg artikkel 2007年论文 vědecký článek 2007年の論文 სამეცნიერო სტატია
p:P577
wds:Q34655367-DFA47228-9277-43F1-8875-19B21EAE3A65
wdt:P577
2007-11-01T00:00:00Z
p:P407
wds:Q34655367-2B46EDFE-1B85-4567-BA1C-E9A0B5D51515
wdt:P407
wd:Q1860
p:P2093
wds:Q34655367-E0FBBEB5-5A84-42B6-BA0E-D0E2272D272B wds:Q34655367-BA330442-0EF9-4339-8821-31AA284F91AA
wdt:P2093
John G F Cleland Jim Lewsey
rdfs:label
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials
skos:prefLabel
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials
schema:name
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials
p:P50
wds:Q34655367-79964338-12F3-44A6-81D4-70782B13236C wds:Q34655367-83CF67B4-6A8C-46D3-A095-AFF2518C8AC3 wds:Q34655367-918272BF-90A5-4BF7-8591-8C67E334A64E wds:Q34655367-5B4702C3-5D7D-49D1-8DC2-4ED73DD99DC9 wds:Q34655367-5BC1131E-80D1-4BD4-BDFE-7969B05163F6 wds:Q34655367-B85C0608-A91D-4286-BED2-613CBC807DDD wds:Q34655367-D370A819-8298-49EF-8AC4-D604DB005F12 wds:Q34655367-95027885-92A0-43FA-9481-126C064AF0CC wds:Q34655367-EC4FFCCD-E9F8-4C77-BFC4-E71E12829A82 wds:Q34655367-D83E3FF3-D6D8-4553-9465-A490C3C30763 wds:Q34655367-E0034715-A562-457E-A9E5-2F26189253EA wds:Q34655367-3A0B396B-AA68-4138-A317-576B3E4BB3CB wds:Q34655367-403400D3-AADD-4820-AC34-7E5A1573BBB9 wds:Q34655367-05CF61F4-DEE2-4765-AE29-F3E34FDFF492 wds:Q34655367-28780A42-932E-44FF-940F-D220BB6BB7F0
wdt:P50
wd:Q114429090 wd:Q114429089 wd:Q82083581 wd:Q64689171 wd:Q39274051 wd:Q82060328 wd:Q56633150 wd:Q95657200 wd:Q88437014 wd:Q90422543 wd:Q84216198 wd:Q106212044 wd:Q114321731 wd:Q99344173 wd:Q43236838
p:P1476
wds:Q34655367-6D6DB9BE-8DFE-46CE-B321-10530B2850E1
wdt:P1476
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials
p:P304
wds:Q34655367-95BBF42C-9072-45C7-BB31-A30650D7414A
wdt:P304
2009-2019
p:P31
wds:Q34655367-AB6E1ED4-01B7-4A9C-AD9C-4D35DD18C88D
wdt:P31
wd:Q13442814
p:P921
wds:Q34655367-019713BF-9D6D-4762-9D4A-C364F0A6A35A wds:Q34655367-27DEC981-85B4-49A3-B486-B3828606DF0F wds:Q34655367-D70E7933-CC2F-40B3-B90F-4E2C049D73FE
wdt:P921
wd:Q181754 wd:Q181600 wd:Q4677930
p:P698
wds:Q34655367-74327D6C-721F-41E0-AC87-596D3E26E088
wdtn:P698
n11:17986694
wdt:P698
17986694
p:P1433
wds:Q34655367-9D499834-3F83-455D-8D43-9F5B0A8FDEF8
wdt:P1433
wd:Q1470970
p:P433
wds:Q34655367-70151439-463B-4637-B23F-08A5D6394868
p:P478
wds:Q34655367-5056AAFB-78DF-47FC-919D-1166FED8AA0A
wdt:P433
17
wdt:P478
298
p:P356
wds:Q34655367-BD01369B-8087-499F-9EED-8AFD714D1C1D
wdtn:P356
n12:JAMA.298.17.2009
wdt:P356
10.1001/JAMA.298.17.2009